Skip to main content

Table 1 Laboratory data from cases

From: Three effective cases of transcatheter arterial embolization after atezolizumab and bevacizumab treatment for hepatocellular carcinoma: a case report

Laboratory data

Case 1

Case 2

Case 3

Hematology

Hematology

Hematology

WBC

RBC

Hb

Plt

4260/µL

432 × 104/µL

14.0 g/dL

13.8 × 104/µL

WBC

RBC

Hb

Plt

5330/µL

447 × 104/µL

13.9 g/dL

13.8 × 104/µL

WBC

RBC

Hb

Plt

3370/µL

426 × 104/µL

9.9 g/dL

13.8 × 104/µL

Biochemistry

Biochemistry

Biochemistry

Alb

T-Bil

3.1 g/dL

1.1 mg/dL

Alb

T-Bil

4.0 g/dL

1.0 mg/dL

Alb

T-Bil

4.2 g/dL

0.6 mg/dL

Coagulation

Coagulation

Coagulation

PT%

105%

PT%

101%

PT%

109%

Viral marker

Viral marker

Viral marker

HBsAg

HCVAb

HCV-RNA

(−)

(+)

(−)

HBsAg

HCVAb

(−)

(−)

HBsAg

HCVAb

HBV-DNA

(+)

(+)

(−)

Tumor marker

Tumor marker

Tumor marker

DCP

AFP

2355 mAU/mL

1.6 ng/mL

DCP

AFP

1232 mAU/mL

14,440 ng/mL

DCP

AFP

66 mAU/mL

36.9 ng/mL

  1. AFP, alpha-fetoprotein; Alb, albumin; DCP, des-γ-carboxy prothrombin; Hb, hemoglobin; HBsAg, hepatitis B surface antigen; HBV-DNA, hepatitis B virus deoxyribonucleic acid; HCVAb, hepatitis C antibody; HCV-RNA, hepatitis C ribonucleic acid; Plt, platelets; PT%, prothrombin time; RBC, red blood cells; T-Bil, total bilirubin; WBC, white blood cells